InvestorsHub Logo
Followers 4
Posts 392
Boards Moderated 0
Alias Born 04/22/2015

Re: bluehorsesho post# 4632

Tuesday, 04/18/2017 9:56:17 AM

Tuesday, April 18, 2017 9:56:17 AM

Post# of 44784
Can you show me the $1400 PPS estimated value is? I think this is the first time I have actually seen a target price this high. If you add all of the indications, conditions and diseases Pluristem is currently interested in, than yeah, I can see a price that could be higher than today. But I think your price is just a "little" too optimistic considering that they do not even have a product available to sell.

Many companies that "Overpromise and Undeliver" have not done so well in the stock market. New technologies and approaches do not always guarantee high profits. Some of course do fantastic. That is where I too hope PSTI is.

My price estimate for ARS approval is somewhere between $4 and $10 considering the ARS market size/ PSTI Market Cap and the initial "Crazed" Demand for a treatment.

I cross my fingers in hopes that something comes our way!